Clinical Trials Browser

Phase 2 × Muscle-Invasive Bladder Carcinoma × Nivolumab × Clear all

NCT04506554 2025-07-04

A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

Phase 2 Active not recruiting

Muscle-Invasive Bladder Carcinoma

NCT05203913 2024-10-04

CNN-BC

Phase 2 Recruiting

Muscle-Invasive Bladder Carcinoma

NCT04876313 2022-04-06

NURE-Combo

Phase 2 Unknown

Muscle-Invasive Bladder Carcinoma